In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.

Kruse, Robert L; Shum, Thomas; Legras, Xavier; Barzi, Mercedes; Pankowicz, Frank P; Gottschalk, Stephen; Bissig, Karl-Dimiter

Kruse, Robert L; Shum, Thomas; Legras, Xavier; Barzi, Mercedes; Pankowicz, Frank P; Gottschalk, Stephen; Bissig, Karl-Dimiter.

Afiliação

Kruse RL; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Shum T; Center for Stem Cells and Regenerative Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Legras X; Translational Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.
Barzi M; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX 77030, USA.
Pankowicz FP; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Gottschalk S; Translational Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.
Bissig KD; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX 77030, USA.

Mol Ther Methods Clin Dev ; 7: 32-41, 2017 Dec 15.

Article em En | MEDLINE | ID: mdl-29018834

Palavras-chave

T cell; bispecific antibody; gene therapy; hepatitis B virus; immunotherapy; liver; viral hepatitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google